| Home | E-Submission | Sitemap | Editorial Office |  
top_img
         
REVIEW ARTICLE 2022 January 25
Reviewing the potential role of radiation therapy in gallbladder cancer: an update
Gallbladder cancer is a highly malignant disease with a poor prognosis. It is the most common cancer of the biliary tract pathway. Although surgery remains the treatment of choice for early-stage disease, majority of the patients presents in locally advanced, unresectable and me...
ORIGINAL ARTICLE 2022 March 28
Limited field adaptive radiotherapy for glioblastoma: changes in target volume and organ at risk doses
Objective: This study aimed to investigate the tumor volume changes occurring during limited-field radiotherapy (RT) for glioblastoma patients and whether a volume-adapted boost planning approach provided any benefit on tumor coverage and normal tissue sparing. Meterials and M...
ORIGINAL ARTICLE 2022 March 25
PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Purpose: This study aimed to determine the correlation between protein induced by vitamin K absence or antagonist-II (PIVKA-II) and stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma (HCC). Materials and Methods: Sixty-one patients received SBRT be...
ORIGINAL ARTICLE 2022 March 15
Trends in the use of radiation for meningioma across the United States
Purpose: Meningiomas are tumors originating from arachnoid cap cells on the surface of the brain or spinal cord. Treatment differs by grade but can consist of observation, surgery, radiation therapy or both. We utilized the National Cancer Database (NCDB) to compare trends in th...
ORIGINAL ARTICLE 2022 March 22
Optimal positive lymph node ratio showing the benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: an exploratory study using the Surveillance, Epidemiology, and End Results data
Purpose: This study aimed to identify the clinical parameters having the beneficial effect of postoperative radiotherapy (PORT) in pathologic N2 (pN2) non-small cell lung cancer (NSCLC) using the Surveillance, Epidemiology, and End Results (SEER) data. Materials and methods: A...
ORIGINAL ARTICLE 2022 March 22
Long-term outcomes of low-dose radiotherapy in Kasabach-Merritt syndrome
Purpose: Reports on results of radiation therapy (RT) for Kasabach-Merritt syndrome (KMS) are limited. We performed a retrospective study to evaluate the response rates and late complications and to determine the adequate RT dose for patients with KMS patients. Materials and Me...
ORIGINAL ARTICLE 2022 February 23
Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy
Purpose: This study aims to investigate the effect of splenectomy on radiation-mediated growth inhibition and immune modulation in lung cancer xenograft models. Materials and Methods: Human non-small cell lung cancer H1299 cells and murine Lewis lung carcinoma LL/2-luc cells w...
ORIGINAL ARTICLE 2022 March 29
PA1 cells containing a truncated DNA polymerase β protein are more sensitive to gamma radiation
Purpose: DNA polymerase β (Polβ) acts in the base excision repair (BER) pathway. Mutations in DNA polymerase β (Polβ) are associated with different cancers. A variant of Polβ with a 97 amino acid deletion (PolβΔ), in heterozygous conditions with wild-type Polβ, was identi...
CASE REPORT 2022 March 3
Radiation therapy in chronic hidradenitis suppurativa: case report
A 26-year-old female presented recurrent painful, carbuncles at both axillae for 10 years. It caused offensive odor and scar. Tissue diagnosis was chronic hidradenitis suppurativa. She was treated using antibiotics followed by multiple excisions with drainage but showed no impro...

If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of Radiation Oncology Journal. Since it is open access journal, the full text is freely available.
Please Sign up.
Current Issue
Volume 40(1); March 2022
RSS feed
Review Article
1 Reviewing the potential role of radiation therapy in gallbladder cancer: an update
Divyesh Kumar, Nali Muni Kiran, Divya Khosla
Radiat Oncol J. 2022;40(1):1-8.   Published online 2022 Jan 25     DOI: https://doi.org/10.3857/roj.2021.00717
                              
Original Articles
Clinical Investigations
9 Limited field adaptive radiotherapy for glioblastoma: changes in target volume and organ at risk doses
Öznur Şenkesen, Evrim Tezcanlı, Mehmet Ufuk Abacıoğlu, Zeynep Özen, Derya Çöne, Halil Küçücük, Evren Ozan Göksel, Alptekin Arifoğlu, Meriç Şengöz
Radiat Oncol J. 2022;40(1):9-19.   Published online 2022 Mar 28     DOI: https://doi.org/10.3857/roj.2021.00542
                              
roj-2021-00542f1.jpgroj-2021-00542f2.jpgroj-2021-00542f3.jpgroj-2021-00542f4.jpgroj-2021-00542f5.jpg
20 PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J. 2022;40(1):20-28.   Published online 2022 Mar 25     DOI: https://doi.org/10.3857/roj.2021.00934
                              
roj-2021-00934f1.jpgroj-2021-00934f2.jpgroj-2021-00934f3.jpgroj-2021-00934f4.jpg
29 Trends in the use of radiation for meningioma across the United States
Hirsch Matani, Stephen Abel, Alexander Yu, Stephen M. Karlovits, Rodney E. Wegner
Radiat Oncol J. 2022;40(1):29-36.   Published online 2022 Mar 15     DOI: https://doi.org/10.3857/roj.2021.00563
                              Supplementary      
roj-2021-00563f1.jpgroj-2021-00563f2.jpgroj-2021-00563f3.jpg
37 Optimal positive lymph node ratio showing the benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: an exploratory study using the Surveillance, Epidemiology, and End Results data
Shiho Lee, O Kyu Noh
Radiat Oncol J. 2022;40(1):37-44.   Published online 2022 Mar 22     DOI: https://doi.org/10.3857/roj.2021.00969
                              Supplementary      
roj-2021-00969f1.jpgroj-2021-00969f2.jpgroj-2021-00969f3.jpgroj-2021-00969f4.jpg
45 Long-term outcomes of low-dose radiotherapy in Kasabach-Merritt syndrome
Dowook Kim, Jung Yoon Choi, Kyung Taek Hong, Hyoung Jin Kang, Il Han Kim, Joo Ho Lee
Radiat Oncol J. 2022;40(1):45-52.   Published online 2022 Mar 22     DOI: https://doi.org/10.3857/roj.2021.00983
                              
roj-2021-00983f1.jpgroj-2021-00983f2.jpgroj-2021-00983f3.jpg
Biology contributions
53 Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy
Yeeun Kim, Changhoon Choi, Jee Hyun Park, Won-Gyun Ahn, Sung-Won Shin, Shin-Yeong Kim, Jae Myoung Noh
Radiat Oncol J. 2022;40(1):53-65.   Published online 2022 Feb 23     DOI: https://doi.org/10.3857/roj.2021.00885
                              
roj-2021-00885f1.jpgroj-2021-00885f2.jpgroj-2021-00885f3.jpgroj-2021-00885f4.jpgroj-2021-00885f5.jpg
66 PA1 cells containing a truncated DNA polymerase β protein are more sensitive to gamma radiation
Anutosh Patra, Anish Nag, Anindita Chakraborty, Nandan Bhattacharyya
Radiat Oncol J. 2022;40(1):66-78.   Published online 2022 Mar 29     DOI: https://doi.org/10.3857/roj.2021.00689
                              Supplementary      
roj-2021-00689f1.jpgroj-2021-00689f2.jpgroj-2021-00689f3.jpgroj-2021-00689f4.jpgroj-2021-00689f5.jpg
Case Report
79 Radiation therapy in chronic hidradenitis suppurativa: case report
Pitchaya Sakyanun, Thirada Vongvanichvathana, Prasert Lertsanguansinchai
Radiat Oncol J. 2022;40(1):79-85.   Published online 2022 Mar 3     DOI: https://doi.org/10.3857/roj.2021.00570
                              
roj-2021-00570f1.jpgroj-2021-00570f2.jpgroj-2021-00570f3.jpgroj-2021-00570f4.jpgroj-2021-00570f5.jpg
Letter to the Editor
86 Comment on “Abscopal effect in the radio and immunotherapy”
François Fabi
Radiat Oncol J. 2022;40(1):86-87.   Published online 2022 Mar 22     DOI: https://doi.org/10.3857/roj.2022.00017
                              
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
HDX Corporation
Elekta Korea
Editorial Office
Department of Radiation Oncology, Seoul National University Hospital,
Hamchun Hall, 6F, 95 Daehak-ro, Jongno-gu, Seoul 03082, Republic of Korea
Tel : +82-2-743-6574
E-mail: roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next